Skip banner links and go to contentU.S. Department of Health & Human Services * National Institutes of Health
National Heart, Lung, and Blood Institute:  Diseases and Conditions Index
Tell us what you think about this site
  Enter keywords to search this site. (Click here for Search Tips)  
U.S. Department of Health & Human Services National Institutes of Health Diseases and Conditions Index NIH Home NHLBI Home About This Site NHLBI Home NHLBI Home Link to Spanish DCI Tell us what you think
 DCI Home: Lung Diseases: LAM: Key Points

      Lymphangioleiomyomatosis
Skip navigation and go to content
What Is ...
Causes
Who Is At Risk
Signs & Symptoms
Diagnosis
Treatments
Living With
Key Points
Links
 

Key Points

  • LAM is a rare lung disease that mostly affects women in their mid-forties. It is sometimes seen in older women as well. It almost never affects men.
  • In LAM, clumps of cells and cysts grow throughout the lungs. Over time, they destroy the normal lung tissue and block the flow of air. They also reduce oxygen intake by the lungs.
  • More than 1 out of every 3 women with LAM develops growths called angiomyolipomas (AMLs) in their kidneys.
  • There are two forms of LAM: sporadic LAM, in which the disease comes on for unknown reasons, and LAM that appears in people with a rare inherited disease called tuberous sclerosis complex (TSC).
  • Doctors do not yet know what causes LAM. The recent discovery of similarities between LAM and TSC has begun to provide some valuable clues about the genes involved in both conditions.
  • The symptoms of LAM include shortness of breath (especially following periods of exertion), chest pain, and a frequent cough, sometimes with bloody phlegm.
  • LAM can lead to other serious conditions, including a collapsed lung, blood in the urine, and abdominal swelling.
  • To confirm or rule out LAM, doctors usually do a chest x ray, lung function tests, blood tests, pulse oximetry, high resolution CT scans, and lung biopsy.
  • Doctors have not yet found any treatments to slow or stop the growth of the cell clusters or cysts that are the main features of LAM. As a result, most treatments are aimed at relieving symptoms and preventing complications. These treatments include inhaled bronchodilators, oxygen therapy, removal of air or fluid from your chest or abdominal cavities, and lung transplantation.
  • Several medicines are now being investigated as possible treatments for LAM, including rapamycin.
  • Most people with LAM can usually continue to be active in the early stages of the disease. If the condition becomes worse, they may not be able to be active, and they may need oxygen full time.

Living WithPrevious  NextLinks


Email this Page Email all Sections Print all Sections Print all Sections of this Topic


Skip bottom navigation and go back to top
Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute
Blood Diseases | Heart and Blood Vessel Diseases | Lung Diseases | Sleep Disorders
NHLBI Privacy Statement | NHLBI Accessibility Policy
NIH Home | NHLBI Home | DCI Home | About DCI | Search
About NHLBI | Contact NHLBI

Note to users of screen readers and other assistive technologies: please report your problems here.